Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
486. |
ECCT/25/11/02 | DELIVER-02 IGHID 12430/DELIVER-02 - A PHASE 1, OPEN LABEL,STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF MGD014 AND MGD020 WITH A LATENCY REVERSAL AGENT VERSUS TEMPORARY TREATMENT INTERRUPTION IN PERSONS WITH HIV-1 ON ANTIRETROVIRAL THERAPY |
Principal Investigator(s) 1. Deborah Chepngeno Langat Site(s) in Kenya 1. Kericho Clinical Research Center (Kericho CRC), Kericho, (Kericho county) 2. MOI UNIVERSITY CLINICAL RESEARCH CENTRE (MUCRC), ELDORET (Uasin Gishu county) |
View |
487. |
ECCT/26/04/02 | IGHID 12430/DELIVER-02 IGHID12430/DELIVER-02 - A PHASE 1, OPEN LABEL,STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF MGD014 AND MGD020 WITH A LATENCY REVERSAL AGENT VERSUS TEMPORARY TREATMENT INTERRUPTION IN PERSONS WITH HIV-1 ON ANTIRETROVIRAL THERAPY |
Principal Investigator(s) 1. Charity Wambui Kanyoro Site(s) in Kenya 1. Moi University Clinical Research Centre(MUCRC), Eldoret, Kenya (Uasin Gishu county) 2. Kericho Clinical Research Center (Kericho CRC), Kericho, (Kericho county) |
View |
488. |
ECCT/18/05/02 | KINGA Study Immunogenetic Modulators of Mucosal Protection from HIV-1: The Kinga Study |
Principal Investigator(s) 1. Nelly Rwamba Mugo Site(s) in Kenya KEMRI-CCR - Partners in Health Research & Development (PHRD) Thika Site. |
View |
489. |
ECCT/12/02/02 | HIV/HPV-Adolescent Study Immunogenicity and Safety of quadrivalent human Papillomavirus Vaccine in HIV-Infected pre-adolescent girls and boys in Kenya. |
Principal Investigator(s) 1. Dr. Nelly Rwamba Mugo Site(s) in Kenya Thika |
View |
490. |
ECCT/17/08/07 | Tambua Mapema Plus Impact of a novel HIV-1 RNA testing intervention to detect acute and prevalent HIV infection and reduce HIV transmission – Tambua Mapema Plus |
Principal Investigator(s) 1. Eduard J Sanders 2. Susan M Graham Site(s) in Kenya KEMRI Mtwapa Research Clinic |
View |